ArticleGut2014
Beyond phase 3 registration trials: defining safety for triple therapy with protease inhibitors in cirrhosis.
P Ferenci et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it
ArticleGut2014
P Ferenci et al.PubMed ↗Publisher ↗
No numbers read from the abstract.